Citation: Mg. Larena et al., Liver organotropism and biotransformation of a novel platinum-ursodeoxycholate derivative, Bamet-UD2, with enhanced antitumour activity, J DRUG TAR, 9(3), 2001, pp. 185-200
Authors:
El-Mir, MY
Badia, MD
Luengo, N
Monte, MJ
Marin, JJG
Citation: My. El-mir et al., Increased levels of typically fetal bile acid species in patients with hepatocellular carcinoma, CLIN SCI, 100(5), 2001, pp. 499-508
Authors:
Dominguez, MF
Macias, RIR
Izco-Basurko, I
De La Fuente, A
Pascual, MJ
Criado, JM
Monte, MJ
Yajeya, J
Marin, JJG
Citation: Mf. Dominguez et al., Low in vivo toxicity of a novel cisplatin-ursodeoxycholic derivative (Bamet-UD2) with enhanced cytostatic activity versus liver tumors, J PHARM EXP, 297(3), 2001, pp. 1106-1112
Authors:
Martinez-Diez, MC
Serrano, MA
Monte, MJ
Marin, JJG
Citation: Mc. Martinez-diez et al., Comparison of the effects of bile acids on cell viability and DNA synthesis by rat hepatocytes in primary culture, BBA-MOL BAS, 1500(2), 2000, pp. 153-160
Citation: Mj. Monte et al., Further evidence of the usefulness of bile acids as molecules for shuttling cytostatic drugs toward liver tumors, J HEPATOL, 31(3), 1999, pp. 521-528
Authors:
Macias, RIR
El-Mir, MY
Monte, MJ
Serrano, MA
Garcia, MJ
Marin, JJG
Citation: Rir. Macias et al., Cholephilic characteristics of a new cytostatic complex of cisplatin with glycocholate (Bamet-R2), J CONTR REL, 57(2), 1999, pp. 161-169